Vaccines Europe

?? The 2024 pipeline review of Vaccines Europe member companies is published today, highlighting the transformative power of immunisation in addressing evolving health challenges such as the ageing population, #AMR, and climate change. With 98 vaccine candidates in our members’ pipeline across 12 different technology platforms, vaccine innovation plays a key role in public health and the resilience of societies and economies https://bit.ly/3ZdJO1U #WeWontRest?

?? I'm looking forward to catching up with some of you next week at the NextGen Biomed conference in London where I will speak about the current vaccine pipeline from Vaccines Europe members & what this tells us about future trends for infectious disease vaccines & mAbs. If you're attending, please come say hi! ?? Curious to know more? Check out our 2024 Vaccine Pipeline Review: https://lnkd.in/eH7UzUZQ

It was an honour to participate in such an insightful event alongside very distinguished experts, where we underscored the critical need to invest in prevention and immunisation. In my contribution, I reinforced that investing in prevention, particularly immunisation, is not just a health measure—it is a strategic imperative: ?? A safeguard for the #resilience of our healthcare systems, society, and economy. ??? A cornerstone of #EUHealthSecurity. #Immunisation is: 1 - A Vital #Shield for Health and Resilience ??? It empowers individuals to protect themselves and those around them. ??? It strengthens healthcare systems, ensuring they remain open and accessible to those who need them most. 2 - An #Investment for Every Stage of Life, Delivering Short-, Mid-, and Long-Term Benefits ??? Health & Wellbeing:?Prevents diseases and their complications. ??? Healthcare system sustainability:?Minimizes healthcare costs and resource use 3 - A key driver of #EconomicResilience, reducing absenteeism and enhancing workforce resilience Immunisation doesn’t just prevent illness—it prevents complications from infections and the management of these complications. The impact is undeniable: ???#Flu increases #HeartAttack risk 6x in #cardiovascular patients. ?? Over 30% of patients hospitalized with #RSV have underlying CVD complications. ?? Immunisation could prevent hundreds of thousands of deaths related to #AMR globally each year. ?? Immunisation prevents infection-related #cancers such as #HPV and #HepB- as referenced by and with concrete recommendations from the #EUBeatingCancerPlan. 4 - A #HighImpact for still low Investment With an?adult immunisation ROI of 19, the #FiscalFlexibility within the #StabilityandGrowthPact presents a?unique opportunity?to increase investment in prevention, esp. immunisation. Currently, prevention represents bearly 3-5% of national healthcare budgets and immunisation just about 0.5%. A budget increase could yield profound benefits for population health in the short, medium, and long term. #TimetoActNow: The Window for #PreventionForChange Is Open With the?upcoming annual update of the Mid-Term Fiscal Plan?(April 2025), Member States can position appropriately investment in prevention & immunisation, to support economic and social resilience, in? #Appendix_VI. Policymakers have the flexibility to make meaningful changes—a rare opportunity to secure a healthier, more resilient future. #Italy?is well placed to pioneer such bold?#PreventionForChange?move Thank you Nicoletta Luppi, Marina Panfilo,?MSD Italia for leading on this important, forward looking, engagement. #WeWontRest #PreventionForChange

In Spain, regional authorities play a key role in implementing vaccination programmes. While all regions follow a national calendar, they have a degree of freedom in how they deliver vaccines. In Galicia, northeastern Spain, a wide range of stakeholders from the public and private sectors are working together to achieve a common goal: better protection against vaccine-preventable diseases. ?? Read the article to find out more: https://lnkd.in/d5XQju-E

???????????? ???? ????????????????????’?? ?????????? ?????????? ???? ???????????????????? ???????????? ??????????????????????????????: ?????? ?????????????????? The Polish presidency of the Council of the European Union recently launched its ?????????? ?????????? ???? ???????????????????? ???????????? ??????????????????????????????, a milestone document shaped by over two years of expert discussions on health priorities. A special thank you to our MBVE members Prof. Marcin Czech and Sibilia Quilici for their valuable contributions to advancing the immunisation agenda! ?? Key Takeaways: ? ????????????????????, ???????????????? ?????? ???????????? ???????????? ???? ?????? ?????????????? ???? ?????? ???????????? ???????????? - Recognising the value of investing in prevention as one of the most effective strategis for improving public health. ? ???????????????? ???????????????? ???? ???????????????????? – Integrating education with access to innovative medical solutions and their timely updates. ? ?????????????????? ?????????????? ?????? ???????????????????? – Boosting financial resources is essential for implementing comprehensive prevention programmes, reducing the disease burden, and enhancing healthcare system resilience. ? ?????????????????? ???????????? ?????????????????????? ???????????????????? – Ensuring access to next-generation vaccines for broader and more robust protection against a wide range of diseases. Investing in vaccination is a forward-looking strategy for long-term public health. ? ?????????????????????????? ?????????????? ?????????????????? – Enhancing communication and public engagement to improve vaccine confidence and uptake. This report, which aligns closely with our mission, reinforces a crucial message: ?????????????????? ???? ???????????????????? ?????? ???????????????????????? ???? ?????????????????? ???? ???????????????? ?????????????????? ?????? ?????????????????????? ???????????????????? ??????????????. ?? What are your thoughts on these recommendations? Let’s continue the conversation! #Healthcare #Prevention #Immunisation #Vaccination #PolishEUPresidency

Manufacturing high-quality, safe and effective vaccines is a highly complex and lengthy process with multiple steps. Up to 70% of the manufacturing time is dedicated to quality controls to ensure vaccines are produced to the highest standards. Learn more: https://bit.ly/4beV6sj #WeWontRest

As the world grapples with current and emerging health challenges, life-course immunisation remains a highly cost-effective public health intervention. Adopting a prevention-first mindset towards health is essential https://bit.ly/4b0is3y #VaccinesForLife #WeWontRest

???? Nel corso della seconda Tavola Rotonda del nostro “Inventing for Life 2025 - Health Summit”, affronteremo un altro tema di particolare importanza ovvero quello della prevenzione da considerara non un costo, ma un investimento. A condividere riflessioni e spunti di valore, ospiti quali: ?? David Bloom, Professore di Economia, Università di Harvard ?? Bordignon Massimo, Professore di Economia Pubblica, Università La Cattolica ?? Americo Cicchetti, Direttore Generale della Programmazione Sanitaria, Ministero della Salute ?? Massimo Garavaglia, Presidente 6a Commissione Finanze, Senato della Repubblica ?? Elisabetta Iannelli, Segretario Generale FAVO ?? Sibilia Quilici, Executive Director of Vaccines Europe A introdurre i lavori, Valerio De Molli, Managing Partner & CEO The European House-Ambrosetti e TEHA Group ? Segui la diretta streaming dell’evento sul sito de Il Sole 24 Ore, cliccando su questo link https://lnkd.in/dBz75ZVF e resta aggiornata/o seguendo i nostri canali social! #MSD #InventingforLife25 #IFL2025

We are still seeing a significant respiratory virus activity in the EU/EEA. The #flu season is in full swing, and an #RSV epidemic is ongoing. Individuals eligible for vaccination are strongly encouraged to get vaccinated. Preventive measures, such as: ?? frequent handwashing ?? maintaining physical distance ?? avoiding large gatherings ?? wearing masks in healthcare settings can help reduce transmission and protect those at high risk of severe illness! Read more about the current situation at https://erviss.org #Influenza #Flu #RespiratoryViruses #VaccinesSaveLives #Prevention #Vaccination #ERVISS

Immunisation has significant public health and socio-economic benefits – and yet, most EU Member States spend less than 0.5% of their healthcare budgets on immunisation. It is time to see immunisation as an investment, not a cost #VaccinesForLife #WeWontRest